Search
for

    Sort by

    Research 181–210 of 1000+

    1. Inibidores das Janus Associated Kinases na Terapêutica Farmacológica 2016 · 1 citations
    2. The role of janus kinases in the treatment of autoimmune skin diseases Farmacja Polska · 2021 · 1 citations
    3. Janus kinase inhibitors for alopecia areata: A narrative review Indian journal of dermatology, venereology, and leprology · 2023 · 2 citations
    4. The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study Journal of Cosmetic Dermatology · 2025 · 5 citations
    5. Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition Journal of Dermatological Treatment · 2026 · 1 citations
    6. 691 Topical curcumin promotes induction of the murine hair cycle 2016 · 3 citations
    7. Title Choice of treatment for severe forms of alopecia areata (case reports) Vestnik dermatologii i venerologii · 2025
    8. Successful treatment of resistant alopecia totalis with tofacitinib Journal of Pakistan Association of Dermatologists · 2024
    9. JAK inhibition in the treatment of alopecia areata – a promising new dawn? Expert review of clinical pharmacology · 2019 · 29 citations
    10. JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia EMBO Molecular Medicine · 2024 · 8 citations
    11. Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis Clinical Journal of Gastroenterology · 2026
    12. Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata Journal of Drugs in Dermatology · 2024 · 4 citations
    13. The Burden of Alopecia Areata and Management with Baricitinib in the United Arab Emirates: A Narrative Review Dermatology and Therapy · 2025
    14. Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor Frontiers in Pediatrics · 2026
    15. Single‐cell transcriptomics reveals a senescence‐associated IL ‐6/ CCR6 axis driving radiodermatitis EMBO molecular medicine · 2022 · 9 citations
    16. Exploring the Use of Topical Tofacitinib in Pediatric Alopecia Totalis International Journal of Trichology · 2025
    17. Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study Frontiers in medicine · 2023
    18. Real-world assessment of ritlecitinib in patients with severe alopecia areata: a 24-week multicentre retrospective study Clinical and Experimental Dermatology · 2025 · 3 citations
    19. Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen European Journal of Dermatology · 2019 · 15 citations
    20. Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms Eurasian Journal of Medicine · 2026
    21. Studi Molecular Docking Aktivitas Anti Alopecia pada Senyawa yang Terkandung dalam Daun Dadap Serep (Erythrina subumbrans (Hassk.) Merrill) FASKES Jurnal Farmasi Kesehatan dan Sains · 2025
    22. Topical metformin as a novel therapy for alopecia areata due to its immunologic effects Medical Hypotheses · 2023
    23. Ann Robinson’s research reviews —12 May 2022 The BMJ · 2022
    24. Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis Journal of Investigative Dermatology · 2014 · 185 citations
    25. Alopecia Areata: a Comprehensive Review of Pathogenesis and Management Clinical Reviews in Allergy & Immunology · 2017 · 99 citations
    26. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition Nature medicine · 2014 · 701 citations
    27. 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2 Journal of The American Academy of Dermatology · 2022 · 4 citations
    28. Hypohidrotic Ectodermal Dysplasia with c.28delG Mutation in Ectodysplasin A Gene and Severe Atopic Dermatitis Treated Successfully with Tofacitinib Acta Dermato Venereologica · 2020 · 4 citations
    29. Deuruxolitinib for Alopecia Areata. PubMed · 2026
    30. 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata 2019